Back to Search
Start Over
Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19.
- Source :
- Open Forum Infectious Diseases; Aug2022, Vol. 9 Issue 8, p1-4, 4p
- Publication Year :
- 2022
-
Abstract
- Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 patients treated with anti-CD20 immunotherapy who acquired severe acute respiratory syndrome coronavirus 2 infection and experienced protracted symptoms. Our results support nucleocapsid antigenemia as a marker of persistent infection and therapeutic response. [ABSTRACT FROM AUTHOR]
- Subjects :
- COVID-19
COVID-19 treatment
CORONAVIRUS diseases
Subjects
Details
- Language :
- English
- ISSN :
- 23288957
- Volume :
- 9
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Open Forum Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 158896566
- Full Text :
- https://doi.org/10.1093/ofid/ofac419